TrialEndocrine2024

Risk of recurrence at the time of withdrawal of short- or long-term methimazole therapy in patients with Graves' hyperthyroidism: a randomized trial and a risk-scoring model.

Fereidoun Azizi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.